COST-EFFECTIVENESS OF SORAFENIB FOR TREATMENT OF RADIOACTIVE IODINE (RAI)-REFRACTORY LOCALLY ADVANCED/METASTATIC DIFFERENTIATED THYROID CANCER (DTC) IN TURKEY

Erdal, E.Sayman, H.Turkmen, C.Aral, F.Yildiz, O.Okutur, K.Parali, E.Deger, C.Tunalioglu, A.Sar, C.Asan, S.Sumer, F.Ozel, O.2023-02-212023-02-212015-01-0110.1016/j.jval.2015.03.1178https://hdl.handle.net/11443/2269http://dx.doi.org/10.1016/j.jval.2015.03.1178COST-EFFECTIVENESS OF SORAFENIB FOR TREATMENT OF RADIOACTIVE IODINE (RAI)-REFRACTORY LOCALLY ADVANCED/METASTATIC DIFFERENTIATED THYROID CANCER (DTC) IN TURKEYArticleWOS:000354498503198